Canada markets close in 1 hour 55 minutes

NeuroSense Therapeutics Ltd. (NRSNW)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.2340-0.0111 (-4.53%)
As of 04:00PM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
7,588
7,588
6,416
3,082
2,495
Selling General and Administrative
5,714
5,714
7,136
2,505
393
Total Operating Expenses
13,302
13,302
13,552
5,587
2,888
Operating Income or Loss
-13,302
-13,302
-13,552
-5,587
-2,888
Interest Expense
11
11
15
0
0
Total Other Income/Expenses Net
2,394
2,394
1,143
2,700
61
Income Before Tax
-11,280
-11,280
-12,340
-4,041
-2,828
Income from Continuing Operations
-11,280
-11,280
-12,340
-4,041
-2,828
Net Income
-11,280
-11,280
-12,340
-4,041
-2,828
Net Income available to common shareholders
-11,280
-11,280
-12,340
-4,041
-2,828